Latest news
Loading news…
Accentia Biopharmaceuticals Inc
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Tampa, Florida, United States Founded 2002 51-100 employees For Profit
Accentia Biopharmaceuticals discovers, develops and commercializes immunotherapies to treat autoimmune-related diseases and cancer.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
10
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Delisted
- Ticker
- ABPI
- Exchange
- NASDAQ
- IPO date
- Oct 28, 2005
- Raised at IPO
- $19M
- Delisted
- Nov 4, 2008
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 6
- Active products
- 7
- Patents granted
- 10
- Trademarks
- 0
- Top patent class
- a61
- IT spend
- $1M
Company Info
- Founded
- 2002
- Employees
- 51-100
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- HQ
- Tampa, Florida, United States
- Region
- Tampa Bay Area, East Coast, Southern US
- Exit date
- Oct 28, 2005
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- 0
- Trend (30d)
- -0.2
- Trend (90d)
- -0.1
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Accentia Biopharmaceuticals Inc
Loading news…
FAQs about Accentia Biopharmaceuticals Inc
People who checked this page also checked these
Browse the full Acquirezy directory.